Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Type 2 Diabetes in Pregnancy (MOMPOD)
NCT02932475Phase 3Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2017
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by University of North Carolina at Chapel Hill. Started May 2017; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02932475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932475.